Zhu Mei

1.2k total citations
22 papers, 850 citations indexed

About

Zhu Mei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhu Mei has authored 22 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Zhu Mei's work include MicroRNA in disease regulation (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Zhu Mei is often cited by papers focused on MicroRNA in disease regulation (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Zhu Mei collaborates with scholars based in China, United States and Bangladesh. Zhu Mei's co-authors include Mingjie Jiang, Dian-na Gu, Ling Tian, Xuebiao Yao, Changjiang Jin, Yu Xue, Xinjiao Gao, Longping Wen, Andrew Shaw and Jian Ren and has published in prestigious journals such as Cancer Cell, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Zhu Mei

21 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhu Mei China	13	609	331	206	94	89	22	850
Jupeng Yuan China	18	633 1.0×	275 0.8×	139 0.7×	145 1.5×	78 0.9×	31	837
Ye Han China	19	521 0.9×	318 1.0×	212 1.0×	73 0.8×	60 0.7×	43	772
Hyang Sook Seol South Korea	15	327 0.5×	228 0.7×	288 1.4×	97 1.0×	84 0.9×	22	754
Yi Sang China	19	885 1.5×	433 1.3×	220 1.1×	98 1.0×	67 0.8×	44	1.1k
Renaud Grépin France	16	601 1.0×	278 0.8×	278 1.3×	150 1.6×	59 0.7×	26	917
Sajjeev Jagannathan United States	11	525 0.9×	260 0.8×	119 0.6×	105 1.1×	102 1.1×	22	735
Kateryna Shostak Belgium	14	648 1.1×	284 0.9×	276 1.3×	129 1.4×	38 0.4×	20	888
Sabine Hünten Germany	7	730 1.2×	539 1.6×	351 1.7×	88 0.9×	49 0.6×	8	1.1k
Xingfeng Qiu China	12	521 0.9×	160 0.5×	141 0.7×	158 1.7×	106 1.2×	24	685
Aiwu Mao China	15	598 1.0×	407 1.2×	182 0.9×	98 1.0×	67 0.8×	33	900

Countries citing papers authored by Zhu Mei

Since Specialization

Citations

This map shows the geographic impact of Zhu Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhu Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhu Mei more than expected).

Fields of papers citing papers by Zhu Mei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhu Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhu Mei. The network helps show where Zhu Mei may publish in the future.

Co-authorship network of co-authors of Zhu Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Zhu Mei. A scholar is included among the top collaborators of Zhu Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhu Mei. Zhu Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mei, Zhu, et al.. (2025). The role of isoniazid dosage and NAT2 gene polymorphism in the treatment of tuberculous meningitis. Frontiers in Immunology. 15. 1535447–1535447.

Jiang, Mingjie, et al.. (2024). Pancreatic cancer cells hijack tumor suppressive microRNA-26a to promote radioresistance and potentiate tumor repopulation. Heliyon. 10(10). e31346–e31346. 1 indexed citations

Jiang, Mingjie, et al.. (2022). cGAS-STING signalings potentiate tumor progression via sustaining cancer stemness. Translational Oncology. 20. 101404–101404. 10 indexed citations

Zou, Changlin, et al.. (2020). MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer. Disease Markers. 2020. 1–13. 23 indexed citations

Jiang, Haiying, et al.. (2019). Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancer. Molecular and Clinical Oncology. 11(3). 301–308. 31 indexed citations

Fang, Chi, Chenyun Dai, Zhu Mei, et al.. (2018). microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings. Journal of Experimental & Clinical Cancer Research. 37(1). 25–25. 42 indexed citations

Mei, Zhu, Yang Shao, Xiaomin Cai, et al.. (2018). SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients. BMC Cancer. 18(1). 479–479. 34 indexed citations

Mei, Zhu, et al.. (2018). Metastatic thymic carcinoid responds to chemoradiation and octreotide. Medicine. 97(47). e13286–e13286. 3 indexed citations

Gu, Dian-na, Mingjie Jiang, Zhu Mei, et al.. (2017). microRNA-7 impairs autophagy-derived pools of glucose to suppress pancreatic cancer progression. Cancer Letters. 400. 69–78. 75 indexed citations

10.

Zhang, Huilin, Xiaofang Yan, Yongli Zhang, et al.. (2017). ROR1 promotes the proliferation of endometrial cancer cells.. PubMed. 10(10). 10603–10610. 3 indexed citations

11.

Li, Jun, Juan Wei, Zhu Mei, et al.. (2017). Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44.. PubMed. 9(1). 146–154. 33 indexed citations

12.

Zhou, Li, Teng Xu, Ying Zhang, et al.. (2016). Transcriptional network in ovarian cancer cell line SKOV3 treated with Pinellia pedatisecta Schott extract. Oncology Reports. 36(1). 462–470. 8 indexed citations

13.

Li, Jie, Ying Xu, Xi‐Dai Long, et al.. (2014). Cbx4 Governs HIF-1α to Potentiate Angiogenesis of Hepatocellular Carcinoma by Its SUMO E3 Ligase Activity. Cancer Cell. 25(1). 118–131. 182 indexed citations

14.

Li, Jie, Ying Xu, Huike Jiao, et al.. (2014). Sumoylation of hypoxia inducible factor-1α and its significance in cancer. Science China Life Sciences. 57(7). 657–664. 19 indexed citations

15.

Mei, Zhu, Huike Jiao, Wei Wang, et al.. (2014). Polycomb chromobox 4 enhances migration and pulmonary metastasis of hepatocellular carcinoma cell line MHCC97L. Science China Life Sciences. 57(6). 610–617. 15 indexed citations

16.

Zhu, Bei, et al.. (2012). Effects of Coupled Plasma Filtration Adsorption on Septic Patients with Multiple Organ Dysfunction Syndrome. Renal Failure. 34(7). 834–839. 25 indexed citations

17.

Li, Jiayue, Zongbin Li, Zhu Mei, et al.. (2012). Mutational analysis of KCNJ11 in Chinese elderly essential hypertensive patients. Journal of Geriatric Cardiology. 9(2). 153–157. 3 indexed citations

18.

Mei, Zhu. (2011). Combination of thalidomide and transcatheter arterial chemoembolization for advanced hepatocellular carcinoma. Zhonghua zhongliu fangzhi zazhi. 1 indexed citations

19.

Ren, Jian, Xinjiao Gao, Changjiang Jin, et al.. (2009). Systematic study of protein sumoylation: Development of a site‐specific predictor of SUMOsp 2.0. PROTEOMICS. 9(12). 3409–3412. 210 indexed citations

20.

Mei, Zhu. (1992). [Influence of dietary selenium level on immune function of rats with esophageal tumors induced by methylbenzylnitrosamine (NMBzA)].. PubMed. 14(1). 42–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact